Skip to main content

Table 3 Cox regression analysis on mortality, 3-level definition of corticosteroid treatment, including CCI (non-rheumatologic comorbidities vs rheumatologic comorbidities only)

From: Influence of initial glucocorticoid co-medication on mortality and hospitalization in early inflammatory arthritis: an investigation by record linkage of clinical and administrative databases

 

HR (95% CI)

Adj HR (95% IC)

No GC

Ref

Ref

GC ≤7.5 mg/day

0.99 (0.53, 1.83)

1.41 (0.73, 2.71)

GC >7.5 mg/day

0.99 (0.47, 2.10)

1.23 (0.52, 2.92)

Female gender

-

0.65 (0.36, 1.18)

Age

-

1.11 (1.07, 1.15)

HAQ

-

1.35 (0.90, 2.04)

CCI >1

-

2.29 (1.23, 4.27)

MTX

-

0.44 (0.21, 0.93)

ACPA

-

1.58 (0.72, 3.46)

  1. GC glucocorticoid, HR hazard ratio, CI confidence interval, HAQ Health Assessment Questionnaire, CCI Charlson Comorbidity Index, MTX methotrexate, ACPA anti-cyclic citrullinated peptide antibodies
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us